Workshop on Platelet Activation at 31st Annual Meeting of the European Society for Clinical Investigation, Kiel, Germany, March 1997: Distinct sequences of the glycoprotein Ib-binding domain of von Willebrand factor involved in shear induced platelet aggregation

Platelets

Volumn 9, Issue 3-4, 1998, Pages 151-153

  Ajzenberg, N ^a,d   Depraetere, H ^a,b   Lacombe, C ^c   Deckmyn, H ^b   Baruch, D ^a  

^a INSERM   (France)

^b UNIVERSITY OF LEUVEN   (Belgium)

^c CNRS   (France)

^d BICÊTRE HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

BOTROCETIN; FC RECEPTOR; GLYCOPROTEIN IB; MEMBRANE RECEPTOR; MONOCLONAL ANTIBODY; VON WILLEBRAND FACTOR;

CONFERENCE PAPER; CONTROLLED STUDY; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN CONFORMATION; PROTEIN DOMAIN; PROTEIN PROTEIN INTERACTION; SHEAR STRESS; THROMBOCYTE AGGREGATION;

EID: 0031838482     PISSN: 09537104     EISSN: None     Source Type: Journal    
DOI: 10.1080/09537109876609     Document Type: Conference Paper

References (8)

1. Kroll MH, Hellums JD, McIntire LV, Schafer AI, Moake JL. Platelets and shear stress. Blood 1996; 88: 1525-41.
2. Moake JL, Turner NA, Stathopoulos NA, Nolasco L, Hellums JD. Involvement of large plasma von Willebrand factor (vWF) multimers and unusually large vWF forms derived from endothelial cells in shear stress-induced platelet aggregation. J Clin Invest 1986; 78: 1456-61.
3. Peterson DM, Stathopoulos NA, Giorgio TD, Hellums JD, Moake JL. Shear-induced platelet aggregation requires von Willebrand factor and platelet membrane glycoproteins Ib and IIb-IIIa. Blood 1987; 69: 625-8.
4. Girma JP, Takahashi Y, Yoshioka A, Diaz J, Meyer D. Ristocetin and botrocetin involve two distinct domains of von Willebrand factor for binding to platelet membrane glycoprotein Ib. Thromb Haemostas 1990; 64: 326-32.
5. Christophe O, Rouault C, Obert B, Pietu G, Meyer D, Girma JP. A monoclonal antibody (B724) to von Willebrand factor recognizing an epitope within the A1 disulphide loop (Cys509-Cys695) discriminates between type 2A and type 2B von Willebrand disease. Br Haematol 1995; 90: 195-203.
6. Pietu G, Ribba AS, Cherel G, Siguret V, Obert B, Rouault C, Ginsburg D, Meyer D. Epitope mapping of inhibitory monoclonal antibodies to human von Willebrand factor by using recombinant cDNA libraries. Thromb Haemostas 1994; 71: 788-92.
7. Lelievre JC, Delgallo H, Lacombe C, Bucherer C. Présentation d'un hémoviscosimètre clinique. J Mal Vasc 1993; 18: 153-6.
8. Konstantopoulos K, Wu KK, Udden MM, Banez EI, Shattil SJ, Hellums JD. Flow cytometric studies of platelet responses to shear stress in whole blood. Biorheology 1995; 32: 73-93.